Fig. 2.

Individual subject values at baseline to day 47 in log anti-KLH IgG1, IgG2 and IgG3. Log₁₀-transformed anti-KLH IgG1 (a), IgG2 (b) and IgG3 (c) by dose and administration group. Bars indicate significant differences in the comparison of mean change from baseline between 2 treatment groups as determined by a Wilcoxon test. The p value associated with the comparison is included at the top of the bar. Antibody levels measured at 0 are set to −1 for the log.